Compounds > xylitol
Page last updated: 2024-08-17

xylitol and lactoferrin

xylitol has been researched along with lactoferrin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delaere, P; Dirix, P; Nuyts, S; Van den Bogaert, W; Vander Poorten, V1
Ammons, MC; Fisher, ST; James, GA; Ward, LS; Wolcott, RD1
Ammons, MC; Dowd, S; James, GA; Ward, LS1
Ammons, MC; James, GA; Ward, LS1
Ammons, MC; Copié, V1

Reviews

1 review(s) available for xylitol and lactoferrin

ArticleYear
Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic.
    Biofouling, 2013, Volume: 29, Issue:4

    Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Biofilms; Clinical Trials as Topic; Drug Synergism; Humans; Iron Chelating Agents; Lactoferrin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Wound Infection; Xylitol

2013

Other Studies

4 other study(ies) available for xylitol and lactoferrin

ArticleYear
Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:12

    Topics: Aged; Aged, 80 and over; Complex Mixtures; Female; Head and Neck Neoplasms; Health Surveys; Humans; Lactoferrin; Lactoperoxidase; Male; Middle Aged; Muramidase; Pain Measurement; Proteins; Psychological Tests; Psychometrics; Quality of Life; Radiation Injuries; Radiation Oncology; Radiotherapy; Radiotherapy Dosage; Risk Factors; Saliva; Salivation; Surveys and Questionnaires; Xerostomia; Xylitol

2007
In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:3

    Topics: Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Drug Synergism; Humans; Lactoferrin; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Wound Infection; Xylitol

2009
Combined treatment of Pseudomonas aeruginosa biofilm with lactoferrin and xylitol inhibits the ability of bacteria to respond to damage resulting from lactoferrin iron chelation.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:4

    Topics: Base Sequence; Biofilms; DNA Primers; Gene Expression Regulation, Bacterial; Iron Chelating Agents; Lactoferrin; Microscopy, Fluorescence; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Pseudomonas aeruginosa; Xylitol

2011
Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings.
    International wound journal, 2011, Volume: 8, Issue:3

    Topics: Anti-Bacterial Agents; Bandages, Hydrocolloid; Biofilms; Drug Synergism; Drug Therapy, Combination; Humans; Lactoferrin; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Pseudomonas aeruginosa; Sensitivity and Specificity; Silver Compounds; Wound Infection; Xylitol

2011